Cumberland Pharmaceuticals (CPIX) Reports Q2 Loss of $0.20

Cumberland Pharmaceuticals (NASDAQ: CPIX) reported Q2 EPS of ($0.20). Revenue for the quarter came in at $166.45 million.

For earnings history and earnings-related data on Cumberland Pharmaceuticals (CPIX) click here.

You May Also Be Interested In

• HSBC Raises S&P500 Target to 8,100
• Morgan Stanley cuts Peloton rating on structural fitness headwinds
• Spyre's SPY003 meets primary endpoint in Phase 2 UC trial